Phase 1 seizure Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
Focal Seizures
Jazz Pharmaceuticals100 enrolled24 locationsNCT07233239
Recruiting
Phase 1Phase 2
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
seizureEpilepsyDrug Resistant Epilepsy+2 more
NaviFUS Corporation8 enrolled3 locationsNCT06388707
Not Yet Recruiting
Phase 1
A Follow-on, Ascending, Single and Multiple Dose(s), Double-Blind, Randomized, Placebo Controlled Study Assessing the Safety, Tolerability, and Pharmacokinetics of OV329 in Healthy Male and Female Participants
Seizure Disorders
Ovid Therapeutics Australia Pty Ltd32 enrolled1 locationACTRN12625001363471
Completed
Phase 1
An ascending, single and multiple dose(s), double-blind, randomized, placebo controlled study assessing the safety, tolerability, and pharmacokinetics of ov329 in healthy male and female participants
rare seizure disorders
Ovid Therapeutics Australia Pty Ltd68 enrolled1 locationACTRN12624000214538
Withdrawn
Phase 1
Repeatability and diurnal variation of eye responses measured with Neuro-Ophthalmic Device (NODe)
epilepsy or any type of seizureMild traumatic brain injury (mTBI) or concussionmedically diagnosed psychiatric disorder
Percy Lazon de la Jara20 enrolled1 locationACTRN12615000371594